Potential Price Increase for Neurocrine Biosciences, Inc. (NBIX) After Recent Insider Activity
Neurocrine Biosciences, Inc.’s recent filing unveils that its Chief Regulatory Officer Delaet Ingrid unloaded Company’s shares for reported $37346.0 on Apr 01 ’24. In the deal valued at $137.30 per share,272 shares were sold. As a result of this transaction, Delaet Ingrid now holds 7,507 shares worth roughly $0.99 million. Then, Delaet Ingrid sold 5,000 […]
NBIX short interest jump by 10.29%, reflecting negative sentiment
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Neurocrine Biosciences, Inc. shares valued at $37,346 were sold by Delaet Ingrid on Apr 01 ’24. At $137.30 per share, Delaet Ingrid sold 272 shares. The insider’s holdings dropped to 7,507 […]
NBIX stock rated a Neutral by Citigroup
Neurocrine Biosciences, Inc.’s filing revealed that its Chief Regulatory Officer Delaet Ingrid unloaded Company’s shares for reported $37346.0 on Apr 01 ’24. In the deal valued at $137.30 per share,272 shares were sold. As a result of this transaction, Delaet Ingrid now holds 7,507 shares worth roughly $1.05 million. Then, Delaet Ingrid sold 5,000 shares, […]
A company insider recently sold 272 shares of Neurocrine Biosciences, Inc. [NBIX]. Should You Sale?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Neurocrine Biosciences, Inc. shares valued at $37,346 were sold by Delaet Ingrid on Apr 01 ’24. At $137.30 per share, Delaet Ingrid sold 272 shares. The insider’s holdings dropped to 7,507 shares worth approximately […]
Neurocrine Biosciences, Inc. (NBIX) gets rating Resumed from Citigroup
In a filing, Neurocrine Biosciences, Inc. revealed its Chief Regulatory Officer Delaet Ingrid unloaded Company’s shares for reported $0.73 million on Mar 21 ’24. In the deal valued at $145.06 per share,5,000 shares were sold. As a result of this transaction, Delaet Ingrid now holds 7,507 shares worth roughly $1.04 million. Then, BENEVICH ERIC sold […]
Neurocrine Biosciences, Inc. (NBIX) Becoming More Attractive for Investors
Neurocrine Biosciences, Inc.’s filing revealed that its Chief Regulatory Officer Delaet Ingrid unloaded Company’s shares for reported $0.73 million on Mar 21 ’24. In the deal valued at $145.06 per share,5,000 shares were sold. As a result of this transaction, Delaet Ingrid now holds 7,507 shares worth roughly $1.05 million. Then, BENEVICH ERIC sold 75,000 […]
Neurocrine Biosciences Inc. (NBIX): The Latest Casualty Of Increased Volatility?
Neurocrine Biosciences Inc. (NASDAQ:NBIX) does about 806.35K shares in volume on a normal day but saw 847325 shares change hands in Friday trading. The company now has a market cap of 10.08B USD. Its current market price is $103.54, marking an increase of 0.73% compared to the previous close of $102.79. The 52 week high […]
